ITK and neoplasm: Taken together, these data illustrated that ITK inhibitor improves the antitumor effects of ICB, by increasing pre-terminally exhausted TCF1 + tumor-specific cells, cells known to be required for the protective effect of ICB, in the draining lymph nodes.